BETNOVATE N

This brand name is authorized in Brazil, Estonia, Hong Kong, Poland

Active ingredients

The drug BETNOVATE N contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII 9IFA5XM7R2 - BETAMETHASONE VALERATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Neomycin UNII 057Y626693 - NEOMYCIN SULFATE

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. Read about Neomycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07CC01	Betamethasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510601609165312, 510601610163311
Country: EE	Ravimiamet	Identifier(s): 1004320
Country: HK	Department of Health Drug Office	Identifier(s): 02810
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100087328, 100087340